Lithium treatment may rewire brain activity to curb suicide risk
A new study has revealed how lithium treatment could help reduce suicide risk by altering brain activity in high-risk patients. Researchers used EEG scans to track changes in electrical signals linked to impulse control. The findings suggest a potential breakthrough in identifying and treating those most vulnerable to repeated suicide attempts. The study, led by Dr. Nicholas Murphy, focused on patients who had survived severe suicide attempts. These individuals showed higher levels of cortical arousal and stronger neural markers of impulsivity compared to psychiatric controls without such histories. Emergency departments often serve as the first point of contact for people in suicidal crises, making them a critical setting for early intervention.
EEG recordings were taken before and after lithium treatment. The results indicated that lithium strengthened brain signals tied to inhibitory control. This improvement suggests better cognitive restraint and more thoughtful decision-making in patients at high risk of future suicide attempts.
Lithium appears to enhance prefrontal cortex function, reinforcing the brain’s ability to slow down impulsive actions. The study also highlighted that EEG patterns could act as biomarkers, helping clinicians identify which patients might benefit most from lithium therapy. This approach moves beyond traditional risk assessments that rely on self-reported symptoms or clinical interviews.
This is the first human trial to show that lithium can produce measurable changes in EEG markers associated with suicidal behaviour. The findings open the door for faster, more objective ways to evaluate suicide risk using biological data rather than subjective evaluations alone. The research provides concrete evidence that lithium can modify brain activity linked to impulsivity in high-risk patients. By using EEG signals as biomarkers, doctors may soon have a more reliable method for assessing suicide risk and tailoring treatments. The study marks a step toward integrating biological indicators into clinical practice for better prevention strategies.
